Pharmacology of erenumab in human isolated coronary and meningeal arteries: Additional effect of gepants on top of a maximum effect of erenumab.
Saved in:
| Title: | Pharmacology of erenumab in human isolated coronary and meningeal arteries: Additional effect of gepants on top of a maximum effect of erenumab. |
|---|---|
| Authors: | de Vries T; Division of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands., Rubio-Beltrán E; Division of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands., van den Bogaerdt A; Heart Valve Department, ETB-BISLIFE, Beverwijk, The Netherlands., Dammers R; Department of Neurosurgery, Erasmus University Medical Center, The Netherlands., Danser AHJ; Division of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands., Snellman J; Novartis Pharma AG, Basel, Switzerland., Bussiere J; Amgen Inc, Thousand Oaks, California, USA., MaassenVanDenBrink A; Division of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands. |
| Source: | British journal of pharmacology [Br J Pharmacol] 2024 Jun; Vol. 181 (12), pp. 1720-1733. Date of Electronic Publication: 2024 Feb 06. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 7502536 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5381 (Electronic) Linking ISSN: 00071188 NLM ISO Abbreviation: Br J Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1476-5381 |
|---|---|
| DOI: | 10.1111/bph.16322 |
